Don't have Telegram yet? Try it now!
https://emerginggrowth.com/emerging-growth-biopharmaceutical-company-affimed-nv-nasdaq-afmd-is-a-buy-despite-clinical-hold-on-afm11/
Emerging Growth Biopharmaceutical Company Affimed NV (NASDAQ: AFMD) is a buy despite clinical hold on AFM11